to your first point, yes sort of, but you're right I went back and re-read the original COBRA announcement and there is info in there about the greater sensitivity in picking up smaller lesions missed elsewhere leading to change in treatment , so that's good.
Ann: Additional COBRA trial data results, page-10
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.22 |
Change
0.000(0.00%) |
Mkt cap ! $1.625B | |||
| Open | High | Low | Value | Volume |
| $5.23 | $5.29 | $5.11 | $3.861M | 741.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1159 | $5.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.22 | 6688 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$5.22 |
Change
0.000 ( 0.26 %) |
||||
| Open | High | Low | Volume | ||
| $5.26 | $5.28 | $5.11 | 196370 | ||
| Last updated 15.59pm 17/06/2024 ? | |||||
| CU6 (ASX) Chart |
